Advances in ADT Part II: A Guide for Urologists

AUAUniversity

Контент предоставлен AUAUniversity and American Urological Association. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией AUAUniversity and American Urological Association или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

9M ago 44:09

MP3•Главная эпизода

Advances in ADT Part II: A Guide for Urologists CME Available: https://auau.auanet.org/node/39385 Release Date: October, 2023 Expiration Date: October, 2024 LEARNING OBJECTIVES After participating in this educational activity, participants will be able to: 1. Recognize and characterize different disease states for advance prostate cancer including M0 HSPC, M1 HSPC, M0 CRPC, and M1 CRPC. 2. Discuss the role of a multidisciplinary shared team approach for the diagnosis and management of advanced prostate cancer. 3. Facilitate discussions with patients and caregivers regarding treatment intensification for advanced prostate cancer. 4. Identify the role of combination therapy with ADT and additional systemic therapy to yield optimal survival outcomes for metastatic prostate cancer. 5. Differentiate mechanisms of action and side effects when ADT is delivered via GnRH agonists vs. antagonists. ACKNOWLEDGEMENTS Independent educational grant support provided by: Myovant Sciences LTD Pfizer, Inc.

342 эпизодов

#Prostate Cancer #Men's Health #AUAUniversity #Health and Well-Being #Podcasting Education #American Urological Association